Biotechnology
Breaking News
Healthcare
Investing News
Market News
The Market Buzz
Breaking News: MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
MindMed (OTCQB: MMEDF) (NEO: MMED), a leading psychedelic medicine biotech company today announced an innovative randomized placebo-controlled study evaluating the effects of daytime and evening administration of low doses...